Showing 1-10 of 10 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Cooperative harmonization and validation of an islet-specific AIM assay | Benaroya Research Institute at Virginia Mason | Karen Cerosaletti | Cures | 01-February-2024 to 31-January-2027 | $299.998,00 |
| Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-June-2024 to 31-December-2026 | $500.000,00 |
| Evaluating tissue transglutaminase as a treatment axis for T1D and beta cell replacement | Benaroya Research Institute at Virginia Mason | Eddie James | Cures | 01-June-2026 to 31-May-2029 | $1.050.000,00 |
| Platforms for Cross-Therapeutic Profiling and Mechanistic Studies of Immune-Modifying Therapies in Type 1 Diabetes | Benaroya Research Institute at Virginia Mason | Dan Campbell | Cures | 01-March-2026 to 28-February-2029 | $1.045.621,50 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704.860,20 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600.000,00 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500.000,00 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Petter Bjornstad | Improving Lives | 01-September-2025 to 31-August-2028 | $2.040.014,30 |
| Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes | University of Washington | Patrick Stayton | Cures | 01-November-2025 to 31-October-2028 | $894.965,96 |
| Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes | University of Washington | Ian De Boer | Improving Lives | 01-September-2023 to 31-March-2028 | $2.107.411,00 |